Requirements For A Novel Inhaled Combination To Improve Management Of Pseudamonas Aeruginosa Infections In Cystic Fibrosis Patients - A Payer Perspective
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.3064
https://www.valueinhealthjournal.com/article/S1098-3015(17)33399-5/fulltext
Title :
Requirements For A Novel Inhaled Combination To Improve Management Of Pseudamonas Aeruginosa Infections In Cystic Fibrosis Patients - A Payer Perspective
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)33399-5&doi=10.1016/j.jval.2017.08.3064
First page :
A800
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
2194